A Mass Balance Study of 14 C‐Labeled JTZ‐951 (Enarodustat), a Novel Orally Available Erythropoiesis‐Stimulating Agent, in Patients With End‐Stage Renal Disease on Hemodialysis

2019 ◽  
Vol 9 (6) ◽  
pp. 728-741 ◽  
Author(s):  
Sudhakar M. Pai ◽  
Jeffrey Connaire ◽  
Hiroyuki Yamada ◽  
Seiji Enya ◽  
Barbara Gerhardt ◽  
...  
Keyword(s):  
Renal Disease ◽  
Mass Balance ◽  
End Stage Renal Disease ◽  
Balance Study ◽  
Mass Balance Study ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document